Regeneron Pharmaceuticals, Inc.
HIGH CONCENTRATION PROTEIN FORMULATION
Last updated:
Abstract:
The present invention pertains to compositions and methods of making high concentration protein formulations of a therapeutic protein.
Status:
Application
Type:
Utility
Filling date:
21 Nov 2019
Issue date:
21 May 2020